TY - JOUR
KW - Substance Use Disorders -- Drug Therapy
KW - buprenorphine
KW - Substance Abuse
KW - Drugs, Non-Prescription
KW - Human
KW - Urinalysis
KW - Substance Abuse Detection
KW - Cross Sectional Studies
KW - Primary Health Care
KW - Chromatography, Liquid
KW - Mass Spectrometry
KW - Multiple Logistic Regression
KW - Descriptive Statistics
KW - Male
KW - Female
KW - Young Adult
KW - Adult
KW - Retrospective Design
KW - Sensitivity and Specificity
KW - Funding Source
AU - Brendan Saloner
AU - Penn Whitley
AU - Leah LaRue
AU - Eric Dawson
AU - Angela Huskey
A1 - 
AD - Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Millennium Health, San Diego, California
BT - JAMA Network Open
C5 - Education & Workforce; Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use
CP - 9
CY - Chicago, Illinois
DO - 10.1001/jamanetworkopen.2021.23019
IS - 9
JF - JAMA Network Open
LA - English
M1 - Journal Article
PB - American Medical Association
PP - Chicago, Illinois
PY - 2021
SN - 2574-3805
SP - e2123019
EP - e2123019
EP - 
T1 - Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database
T2 - JAMA Network Open
TI - Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database
U1 - Education & Workforce; Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1001/jamanetworkopen.2021.23019
UR - https://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=152365677&site=ehost-live
VL - 4
VO - 2574-3805
Y1 - 2021
Y2 - 09/10
ER -